L
L

Lyft

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Biden told it will take two weeks to have definitive data on Omicron variant

By Susan Heavey WASHINGTON, Nov 28 (Reuters) - The top U.S. infectious disease official, Dr. Anthony Fauci, told President Joe Biden on Sunday it will take about two weeks to have definitive information on the new coronavirus variant Omicron that has sparked new travel restrictions and shaken financial markets. Biden, returning to Washington follow
P
L
U

KKR's Bae, Nuttall succeed Kravis, Roberts as co-CEOs

By Chibuike Oguh Oct 11 (Reuters) - KKR & Co Inc KKR.N said on Monday it has elevated its co-presidents Scott Nuttall and Joseph Bae to co-chief executive officers, succeeding the storied private equity firm's billionaire co-founders Henry Kravis and George Roberts. The transition has been in the works for years and is unlikely to surprise the firm
G
L

KKR's Bae, Nuttall succeed founders as co-CEOs

By Chibuike Oguh Oct 11 (Reuters) - KKR & Co Inc KKR.N said on Monday it has elevated its co-presidents Scott Nuttall and Joseph Bae to co-chief executive officers, succeeding the storied private equity firm's billionaire co-founders Henry Kravis and George Roberts. The transition has been in the works for years and is unlikely to surprise the firm
G
L

New York Times business news - Aug. 5

Aug 5 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - The White House is vetting Saule Omarova, a Cornell professor, for the role of comptroller of the currency. Link - A coalition of gig economy companies that includes Uber Technolog
L
U

New York Times business news - July 22

July 22 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - U.S. President Biden said on Wednesday he expected the Food and Drug Administration would give final approval quickly for coronavirus vaccines, as he pressed for skeptical Americ
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.